Updated Jul 16, 2026 · Last SEC filing 2026-07-11
RIGEL PHARMACEUTICALS INC (RIGL) has filed 20 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-11. 6 Form 8-K material event filings were reported by RIGL in the last 90 days. 2 Form 144 notices of proposed sale were filed for RIGL stock. InsiderAlpha tracks every RIGL SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001034842 |
|---|
| Form 4 filings (90d) | 20 |
|---|---|
| Form 8-K filings (90d) | 6 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-07-11 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| HANNAH ALISON L. | EVP, Chief Medical Officer | A — Grant or award | 24.4K | $0.00 | — | SEC | |
| Ali-Jackson Kamil | Insider | S — Open-market sale | 2.5K | $35.00 | $88K | SEC | |
| Rojkjaer Lisa | EVP, Chief Medical Officer | F — Tax withholding / forfeiture | 850 | $29.86 | $25K | SEC | |
| Schorno Dean L | EVP & Chief Financial Officer | M — Option exercise | 2.2K | $12.70 | $28K | SEC | |
| RODRIGUEZ RAUL R | CEO, President | F — Tax withholding / forfeiture | 2.4K | $29.86 | $72K | SEC | |
| Santos David A | EVP, Chief Commercial Officer | F — Tax withholding / forfeiture | 874 | $29.86 | $26K | SEC | |
| Schorno Dean L | EVP & Chief Financial Officer | F — Tax withholding / forfeiture | 928 | $29.86 | $28K | SEC | |
| Furey Raymond J. | EVP, GC, CCO & Corp Sec | F — Tax withholding / forfeiture | 877 | $29.86 | $26K | SEC | |
| Schorno Dean L | EVP & Chief Financial Officer | M — Option exercise | 1.2K | $18.70 | $22K | SEC | |
| Ali-Jackson Kamil | Insider | S — Open-market sale | 2.5K | $29.17 | $73K | SEC | |
| MOOS WALTER H | Insider | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| LAPOINTE ANTHONY GREGG | Insider | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| Wasman Jane | Insider | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| Ali-Jackson Kamil | Insider | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| HANNAH ALISON L. | Insider | A — Grant or award | 5.8K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for RIGEL PHARMACEUTICALS INC (RIGL). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Schorno Dean L | 6 | $78K |
| Rojkjaer Lisa | 3 | $25K |
| Ali-Jackson Kamil | 3 | $160K |
| Santos David A | 2 | $26K |
| Furey Raymond J. | 2 | $26K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in RIGL insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live RIGL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.